FDA’s FY 23 budget request asks for additional funds to build upon IT modernization and align cyber practices.
Federal health IT leaders highlight how training the workforce, recognizing business needs and building trust are key for successful data modernization.
IT has a big role in HHS's proposed budget to boost various responsibilities in public health management as well as access to health care.
Robert Califf aims to better leverage health technologies to advance health care and equity.
FDA's Heather Agler from CDRH talks leveraging lessons learned from COVID-19 to improve supply chain resiliency and develop new solutions.
A newly created role overseeing the agency's medical device office is tackling evolving health priorities.
Federal technology leaders outline the connection between workforce and CX to improve mission outcomes.
Senate confirms Robert Califf as FDA commissioner and Sohail Chaudhry takes on CTO full time.
Agencies continue their whole-of-government response to COVID-19, expanding testing, vaccines and tracking.
FDA is developing new guidance for medical device security as the cyber threat landscape expands.
Federal health officials outline new and ongoing efforts to combat COVID-19 as omicron variant surges.
The technique aims to treat some diseases by gene replacement.
Smarter modernization, data, automation, as well as customer and digital services will see the spotlight in 2022.
Cyber experts at FDA unpack how it is shaping guidance for threat modeling to secure medical devices and health data.
FDA, ONC and VA leaders address how they’re improving data flows to bolster IT infrastructures.
Newly confirmed CIO Vid Desai discusses how his role has evolved following the creation of FDA's Digital Transformation Office.
Both Moderna and Johnson & Johnson COVID-19 vaccines are approved for some vaccinated individuals while the agency reviews more data.
A group of IT specialists and scientists are fostering collaboration to enact transformational changes across the agency.
Dr. Rochelle Walensky discusses CDC’s booster dose decision for some individuals and next steps in the regulatory process.